Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 51 to 60 of 350 resources

  • EASL Recommendations on Treatment of Hepatitis C 2016
    These EASL Recommendations on Treatment of Hepatitis C are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the current optimal management of patients with acute and chronic HCV infections. These recommendations apply to therapies that have been approved by the European Medicines Agency and other national European agencies at the time of their publication.
    Rest of World Sep 2016 Other, Reports & Research PDF
  • EASL Recommendations on Treatment of Hepatitis C: 2014
    These EASL Recommendations on Treatment of Hepatitis C are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decisionmaking process by describing the optimal management of patients with acute and chronic HCV infections. These guidelines apply to therapies that will be approved within less than 6 months at the time of their publication.
    UK Apr 2014 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • East Midlands Specialised Commissioning Group Commissioning Policy for Hepatitis C Treatments
    This commissioning policy paper was produced for the treatment of patients with Hepatitis C in the East Midlands, with the aim of providing and ensuring equity, consistency and clarity in approach to treatment across the region. The document sets out the position of East Midlands Specialised Commissioning Group PCTs in respect of treatment for Hepatitis C for its current and future patients, outlining the treatment regimens for the various different genotypes of Hepatitis C using combination therapy (pegylated interferon alpha and weight-based ribavirin).
    East Midlands Jun 2009 Case study, Tools & Templates, Strategy & Planning PDF
  • Eliminating Hepatitis C in England
    In September 2017, the All-Party Parliamentary Group (APPG) on Liver Health launched an inquiry into achieving the elimination of hepatitis C in England. Three oral evidence sessions were held in October, featuring a range of expert stakeholders answering questions from APPG members. The APPG also received written submissions of evidence from individuals and organisations. Following the inquiry this report, 'Eliminating Hepatitis C in England', was produced, gathering the evidence received and setting out recommendations for action to ensure a hepatitis C-free England.
    England Reports & Research, Strategy & Planning PDF
  • Eliminating Hepatitis C in Scotland: A Call to Action
    The Hepatitis C Trust, following an inquiry held with the cross-party Scottish Hepatitis C Parliamentary Champions group, published a report, 'Eliminating Hepatitis C in Scotland: A Call to Action'. The report looks in detail at Scotland's approach to hepatitis C, focusing on the need for an elimination strategy, awareness, prevention, testing & diagnosis, linkage to care, access to treatment and funding. The report also features a series of recommendations for action to boost Scotland's progress towards achieving elimination.
    UK, Scotland Reports & Research, Strategy & Planning PDF
  • EMCDDA on models of care for hepatitis C in drugs services
    The European Monitoring Centre for Drugs and Drug Addiction published 'Hepatitis C: new models of care for drugs services' in July 2019. This aims to highlight the importance of targeting people who inject drugs as a key population for the elimination of hepatitis C in Europe and to show innovative practice in the form of 11 case studies (three of which are from England). The report provides key insights into the results, impact, sustainability and transferability of each practice to guide the implementation of these new models of care in other countries and settings.
    UK, Rest of World, England, Greater London 29 Jul 2019 Reports & Research, Strategy & Planning PDF
  • Enhanced surveillance of blood borne virus in drug users in Wales. Six monthly report: October 2010 to March 2011
    The first in a series of reports for a project surveying blood borne viruses among drug users in Wales. Data presented in this report are for clients seen by substance misuse services between October 2010 and March 2011.
    Wales 2011 Reports & Research PDF
  • Equity and excellence: Liberating the NHS
    This White Paper sets out the long-term plan for the NHS in this Parliamentary term and beyond. The Government states that it will give the NHS a coherent, stable, enduring framework for quality and service improvement. It aims for the debate on health to no longer be about structures and processes, but about priorities and progress in health improvement for all. This is a challenging and far-reaching set of reforms, which will drive cultural changes in the NHS. It sets out plans for managing change, including the transitional roles of strategic health authorities and primary care trusts.
    England Jul 2010 Other PDF
  • Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners
    This study evaluates peer-supported screening as a model of active HCV case finding within prisons with a secondary aim to describe the HCV cascade among those infected including linkage to care and treatment outcomes. The study was carried out in a medium-security Irish male prison with over 500 inmates. The authors conclude that peer-supported screening is an effective active HCV case-finding model to find and link prisoners with untreated active HCV infection to HCV care.
    Rest of World 09 Jul 2019 Reports & Research PDF
  • Evaluation of HepCATT intervention in primary care services
    A new study published this week in the British Journal of General Practice looked at a randomised control trial run in 45 primary care practices in south west England called the Hepatitis C Assessment Through to Treatment (HepCATT). The intervention aimed to increase case-finding, testing, and treatment of HCV through various initiatives in primary care, such as learning resources for staff, leaflets and information for patients, and software identifying patients with risk factors for hepatitis C infection.
    UK, South West Reports & Research PDF

Pages